{"id":23640,"date":"2016-09-07T09:47:46","date_gmt":"2016-09-07T08:47:46","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=23640"},"modified":"2016-09-07T09:47:46","modified_gmt":"2016-09-07T08:47:46","slug":"situacions-especials-i-complicacions-en-el-pacient-diabetic","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/es\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/","title":{"rendered":"Situaciones especiales y complicaciones en el paciente diab\u00e9tico"},"content":{"rendered":"<p>La diabetes es la alteraci\u00f3n endocrina m\u00e1s conocida y ampliamente estudiada. Esta enfermedad cr\u00f3nica en la que cambiar de estilo de vida es fundamental, <b>puede acarrear complicaciones agudas o cr\u00f3nicas si no est\u00e1 convenientemente tratada. <\/b>A largo plazo, la hiperglucemia cr\u00f3nica de la diabetes va asociada a lesiones, disfunciones y quiebras de diversos \u00f3rganos, especialmente los ojos, ri\u00f1ones, nervios, coraz\u00f3n y vasos sangu\u00edneos. Para dar respuesta a estas situaciones, el farmac\u00e9utico debe tener la base cient\u00edfica que permite realizar una intervenci\u00f3n eficaz tanto a escala individual como colectivo para prevenir las posibles complicaciones de la enfermedad.<\/p>\n<p style=\"text-align: left;\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/curs-diabetis-COFB-1.jpg\"><img fetchpriority=\"high\" decoding=\"async\" class=\"wp-image-23647 aligncenter\" alt=\"curs-diabetis-COFB (1)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/curs-diabetis-COFB-1.jpg\" width=\"555\" height=\"291\" \/><\/a><br \/>\nEn el primer semestre del a\u00f1o, el COFB program\u00f3 un <b>curso por situaciones especiales y complicaciones en el paciente diab\u00e9ticos<\/b>. La formaci\u00f3n cont\u00f3 con <b>Rosa Corcoy<\/b>, m\u00e9dica adjunta del Servicio de Endocrinolog\u00eda del Hospital de Sant Pau y coordinadora de la cl\u00ednica de endocrinopat\u00eda y gestaci\u00f3n; <b>Bel\u00e9n Dalama<\/b>, endocrin\u00f3loga del Servicio de Endocrinolog\u00eda de Vall d&#039;Hebron especializada en el manejo del paciente diab\u00e9tico policomplicado; <b>Albert Goday<\/b>, jefe de Secci\u00f3n de Endocrinolog\u00eda del Parc Salut Mar, investigador del grupo de investigaci\u00f3n en riesgo cardiovascular y nutrici\u00f3n del IMIM y organizador del pr\u00f3ximo Congreso de la Sociedad Catalana de Diabetes; y <b>Jordi Mesa<\/b>, jefe de Endocrinolog\u00eda del Hospital Vall d&#039;Hebron.<\/p>\n<figure id=\"attachment_23645\" aria-describedby=\"caption-attachment-23645\" style=\"width: 268px\" class=\"wp-caption alignright\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/conferencia-diabetis-COFB-juny-2.jpg\"><img decoding=\"async\" class=\"wp-image-23645\" alt=\"conferencia-diabetis-COFB-juny (2)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/conferencia-diabetis-COFB-juny-2.jpg\" width=\"268\" height=\"179\" \/><\/a><figcaption id=\"caption-attachment-23645\" class=\"wp-caption-text\">Albert Goday, jefe de Secci\u00f3n de Endocrinolog\u00eda del Parc Salut Mar<\/figcaption><\/figure>\n<p>Como clausura del curso, y en abierto para todos los colegiados, el 16 de junio tuvo lugar una <b>conferencia sobre perspectivas de futuro en diabetolog\u00eda<\/b> a cargo de uno de los docentes del curso, Albert Goday. En esta conferencia se habl\u00f3 de la evoluci\u00f3n en aumento de la prevalencia de la diabetes tipo 2 en Espa\u00f1a \u2013actualmente un 13,79%\u2013, prevalencia m\u00e1s frecuente en mujeres hasta los 75 a\u00f1os, para despu\u00e9s invertirse la tendencia y ser m\u00e1s prevalente en hombres.<\/p>\n<p>&nbsp;<\/p>\n<figure id=\"attachment_23648\" aria-describedby=\"caption-attachment-23648\" style=\"width: 298px\" class=\"wp-caption alignleft\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/curs-diabetis-COFB-2.jpg\"><img decoding=\"async\" class=\"wp-image-23648\" alt=\"curs-diabetis-COFB (2)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/curs-diabetis-COFB-2.jpg\" width=\"298\" height=\"199\" \/><\/a><figcaption id=\"caption-attachment-23648\" class=\"wp-caption-text\">Merc\u00e8 Barau durante la presentaci\u00f3n del curso, en el mes de febrero<\/figcaption><\/figure>\n<p>&nbsp;<\/p>\n<div class=\"box shadow\">Se repasaron las diferentes estrategias farmacol\u00f3gicas para abordar la enfermedad, haciendo m\u00e1s \u00e9nfasis en las m\u00e1s nuevas \u201ccomo es el caso de las <b>gliptinas (inhibidores de la DPP4)<\/b> que potencian la actividad de las incretinas GLP1 y GIP sobre el p\u00e1ncreas al retrasar su inactivaci\u00f3n sin producir hipoglucemias, ni aumento de peso; o los <b>agonistas del GLP1<\/b>, unos inyectables que act\u00faan sobre los factores que regulan la glucosa postpandrial estimulando la liberaci\u00f3n de insulina y disminuyendo la de glucag\u00f3n, uno de ellos el <b>liraglutide<\/b>, es un f\u00e1rmaco que actualmente se puede utilizar en el tratamiento de la obesidad; y por \u00faltimo, se habl\u00f3 de las <b>glifozines<\/b>, unos glucos\u00faricos que act\u00faan a nivel glom\u00e9rulo renal bloqueando la reabsorci\u00f3n de glucosa y favoreciendo su excreci\u00f3n por la orina, pero se debe ir con cuidado porque a la vez incrementa el riesgo de infecciones genito-urinarias\u201d explica <b>Merc\u00e8 Barau, coordinadora del curso y anterior vocal de la Junta de Gobierno del COF Barcelona<\/b>.<\/div>\n<p>\u201cEn la conferencia tambi\u00e9n se record\u00f3 <b>que todas las gu\u00edas de consenso recomiendan como primer f\u00e1rmaco de elecci\u00f3n la metformina<\/b>, se hizo un repaso a las insulinas y se comentaron las nuevas que se han incorporado ahora. Se presentaron los nuevos aparatos para medir la glucosa, como el continuo sensor que no necesitan pincharse, o aparatos para inyectarse insulina como son las bombas, y se habl\u00f3 de la cirug\u00eda bari\u00e1trica y metab\u00f3lica como, de momento, \u00fanica estrategia para dejar de ser diab\u00e9tico, comentando el trasplante de los islotes de las c\u00e9lulas pancre\u00e1ticas como una l\u00ednea en la que seguir investigando\u201d comenta Barau. Para finalizar, se explicaron cu\u00e1les son las nuevas dianas terap\u00e9uticas como las actuaciones sobre la microbiota de la tripa o la grasa parda o la posibilidad de terapia g\u00e9nica.<\/p>\n<p style=\"text-align: center;\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/conferencia-diabetis-COFB-juny-3.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-23646 aligncenter\" alt=\"conferencia-diabetis-COFB-juny (3)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/07\/conferencia-diabetis-COFB-juny-3.jpg\" width=\"593\" height=\"312\" \/><\/a><\/p>\n<p align=\"right\"><b>Con la colaboraci\u00f3n de:<\/b><\/p>\n<p align=\"right\"><a href=\"http:\/\/www.janssen.com\/es\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-6780 alignright\" alt=\"janssen_logo\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2014\/06\/janssen_logo.jpg\" width=\"100\" height=\"49\" \/><\/a><\/p>\n<p align=\"right\">","protected":false},"excerpt":{"rendered":"<p>La diabetes es la alteraci\u00f3n endocrina m\u00e1s conocida y ampliamente estudiada. Esta enfermedad cr\u00f3nica en la que cambiar de estilo de vida es fundamental, puede acarrear complicaciones agudas o cr\u00f3nicas si no est\u00e1 convenientemente tratada. A largo plazo, la hiperglucemia cr\u00f3nica de la diabetes va asociada a lesiones, disfunciones y quiebras [\u2026]<\/p>","protected":false},"author":1,"featured_media":23646,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[57],"tags":[64,197,2465,2466],"class_list":["post-23640","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mon-collegial","tag-atencio-farmaceutica","tag-diabetis","tag-diabetologia","tag-pacient-diabetic"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Situacions especials i complicacions en el pacient diab\u00e8tic - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Situacions especials i complicacions en el pacient diab\u00e8tic - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"La diabetis \u00e9s l\u2019alteraci\u00f3 endocrina m\u00e9s coneguda i m\u00e9s \u00e0mpliament estudiada. Aquesta malaltia cr\u00f2nica en la qual canviar d\u2019estil de vida \u00e9s fonamental, pot comportar complicacions agudes o cr\u00f2niques si no est\u00e0 convenientment tractada. A llarg termini, la hipergluc\u00e8mia cr\u00f2nica de la diabetis va associada a lesions, disfuncions i fallides [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2016-09-07T08:47:46+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Situacions especials i complicacions en el pacient diab\u00e8tic\",\"datePublished\":\"2016-09-07T08:47:46+00:00\",\"dateModified\":\"2016-09-07T08:47:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/\"},\"wordCount\":704,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"Atenci\u00f3 farmac\u00e8utica\",\"diabetis\",\"diabetologia\",\"pacient diab\u00e8tic\"],\"articleSection\":[\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/\",\"name\":\"Situacions especials i complicacions en el pacient diab\u00e8tic - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2016-09-07T08:47:46+00:00\",\"dateModified\":\"2016-09-07T08:47:46+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Situacions especials i complicacions en el pacient diab\u00e8tic\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Situacions especials i complicacions en el pacient diab\u00e8tic - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/","og_locale":"es_ES","og_type":"article","og_title":"Situacions especials i complicacions en el pacient diab\u00e8tic - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"La diabetis \u00e9s l\u2019alteraci\u00f3 endocrina m\u00e9s coneguda i m\u00e9s \u00e0mpliament estudiada. Aquesta malaltia cr\u00f2nica en la qual canviar d\u2019estil de vida \u00e9s fonamental, pot comportar complicacions agudes o cr\u00f2niques si no est\u00e0 convenientment tractada. A llarg termini, la hipergluc\u00e8mia cr\u00f2nica de la diabetis va associada a lesions, disfuncions i fallides [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2016-09-07T08:47:46+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrito por":"wpAdminCofbOrg","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Situacions especials i complicacions en el pacient diab\u00e8tic","datePublished":"2016-09-07T08:47:46+00:00","dateModified":"2016-09-07T08:47:46+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/"},"wordCount":704,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/#primaryimage"},"thumbnailUrl":"","keywords":["Atenci\u00f3 farmac\u00e8utica","diabetis","diabetologia","pacient diab\u00e8tic"],"articleSection":["M\u00f3n col\u00b7legial"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/","url":"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/","name":"Situacions especials i complicacions en el pacient diab\u00e8tic - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/#primaryimage"},"thumbnailUrl":"","datePublished":"2016-09-07T08:47:46+00:00","dateModified":"2016-09-07T08:47:46+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2016\/09\/07\/situacions-especials-i-complicacions-en-el-pacient-diabetic\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Situacions especials i complicacions en el pacient diab\u00e8tic"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"La diabetis \u00e9s l\u2019alteraci\u00f3 endocrina m\u00e9s coneguda i m\u00e9s \u00e0mpliament estudiada. Aquesta malaltia cr\u00f2nica en la qual canviar d\u2019estil de vida \u00e9s fonamental, pot comportar complicacions agudes o cr\u00f2niques si no est\u00e0 convenientment tractada. A llarg termini, la hipergluc\u00e8mia cr\u00f2nica de la diabetis va associada a lesions, disfuncions i fallides [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/23640","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/comments?post=23640"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/23640\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media?parent=23640"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/categories?post=23640"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/tags?post=23640"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}